menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Merck’s $8 billion cancer vaccine faces first U.S. jury trial

7 8
28.01.2025
Jurors will weigh whether Merck withheld side-effect reports from drug regulators and launched misleading marketing campaigns to turn the drug into a blockbuster product.

© Fortune